Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Sanofi's Diabetes Drug Faces Scrutiny from FDA

May 24, 2016 | by Ryan Bushey, Digital Editor | Articles | Comments

An FDA advisory panel is meeting Wednesday to decide if this drug should be recommended for approval in the U.S. 

TOPICS:

New Valeant CEO Discusses Turnaround Plan at Investor Conference

May 24, 2016 3:18 pm | by Ryan Bushey, Digital Editor | Articles | Comments

Joseph Papa shed on light on the potential strategy for reducing the drug maker's debt load.

TOPICS:

EMA Accepts Submission for Rituximab Biosimilar

May 24, 2016 3:00 pm | News | Comments

Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars.

TOPICS:

EU Lifts Suicide Warning on Pfizer's Smoking-Cessation Pill

May 24, 2016 2:00 pm | by Linda A. Johnson, AP Medical Writer | News | Comments

Europe's main drug regulator has lifted a 7-year-old warning about possible suicidal risks from Chantix, Pfizer's smoking-cessation pill.

TOPICS:
Advertisement

Breakthrough Could Help Sufferers of Deadly Lung Disease

May 24, 2016 1:00 pm | by University of Sheffield | News | Comments

For the first time scientists have identified a molecule that promotes the progression of the disease which affects 6,500 people in the UK.

TOPICS:

Combination Immunotherapy Set to Become Integral Element of Renal Cell Carcinoma Treatment

May 24, 2016 11:39 am | by Maxime Bourgognon, PharmD, Oncology and Hematology Analyst, GlobalData | Articles | Comments

Combination approaches have the potential to generate twice as many sales in the recurrent RCC market.

TOPICS:

Janssen's Stelara Maintained Clinical Remission After Year Of Treatment

May 24, 2016 9:21 am | News | Comments

Janssen Phase 3 data presented for the first time at Digestive Disease Week 2016 showed that a significantly greater proportion of adult patients with moderate to severe Crohn's disease receiving Stelara (ustekinumab) subcutaneous (SC) maintenance therapy were in clinical remission at one year. 

TOPICS:

Breast Cancer Drug Discovery Offers Hope for New Treatments

May 24, 2016 8:41 am | by University of Edinburgh | News | Comments

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.

TOPICS:

Yellow Fever Epidemic Threatens Spread from Angola to China

May 24, 2016 8:39 am | by Elsevier Health Sciences | News | Comments

The spread of yellow fever is a global health threat.

TOPICS:
Advertisement

Catching Metastatic Cancer Cells Before They Grow Into Tumors

May 24, 2016 8:38 am | by Rachel M. Dudek and Lonnie Shea, University of Michigan, The Conversation | News | Comments

“Cure” is a word that’s dominated the rhetoric in the war on cancer for decades.

TOPICS:

Astellas, Daiichi Sankyo, and Takeda Announce R&D Collaboration on Biomarker Database

May 23, 2016 2:57 pm | News | Comments

All three firms aim to contribute to the enhancement of health and welfare of people around the world through creating innovative medicine.

TOPICS:

Harvard Licenses Genotyping Platform

May 23, 2016 2:00 pm | by Harvard Gazette | News | Comments

The technology addresses the profound challenge of drug resistance among HIV-infected patients in resource-poor areas.

TOPICS:

One Step Closer to Curing Diabetes

May 23, 2016 1:00 pm | by University of Technology, Sydney | News | Comments

The group is now working with US clinical stage biotechnology company PharmaCyte Biotech to commercialize the research.

TOPICS:

Novartis' Entresto Gains Strong Recommendation for US, EU Heart Failure Guidelines

May 23, 2016 9:48 am | News | Comments

This decision was made less than a year after regulatory approvals. 

TOPICS:

FDA Questions Novo's Phase 3 Data for Diabetes Drug

May 23, 2016 9:07 am | by Ryan Bushey, Digital Editor | Articles | Comments

This drug is projected to be an important source of revenue for Novo Nordisk.

TOPICS:

Breaking Down Cancer Cell Defenses

May 23, 2016 8:52 am | by University of Pennsylvania | News | Comments

The mistaken activation of certain cell-surface receptors contributes to a variety of human cancers.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading